- Sector
- Financial Services
- Industry
- Asset Management - Income
- Address
- 1 Iron Street Boston MA United States of America 2210
- IPO Date
- May 30, 2013
- Business
- SPDR S&P Global Dividend ETF (WDIV) is an exchange-traded fund that seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Global Dividend Aristocrats Index; the index tracks high dividend-yielding companies from the S&P Global Broad Market Index (BMI) that have increased or maintained stable dividends for at least 10 consecutive years, with constituents selected and weighted based on dividend yield. The ETF holds approximately 100 to 122 equity securities across diverse sectors including financials, utilities, real estate, communication services, industrials, health care, materials, consumer staples, energy, consumer discretionary, and information technology; top holdings as of recent data include CSPC Pharmaceutical Group Limited, APA Group, Altria Group Inc., LG Uplus Corp., TELUS Corporation, Henderson Land Development Co Ltd, Bouygues SA, Sino Land Co., Far East Horizon Limited, and EDP S.A. WDIV offers investors exposure to global large-cap value stocks with a focus on consistent dividend payers, exhibiting characteristics such as a dividend yield around 4-5%, price/earnings ratio of approximately 13-14, and assets under management of about $225 million. Launched on May 29, 2013, and issued and managed by State Street Global Advisors (SSGA), a division of State Street Corporation headquartered in Boston, Massachusetts, the fund operates primarily on U.S. exchanges like NYSE Arca while providing geographic diversification across developed and emerging markets including the United States (approximately 20%), Canada (20%), Japan (11%), China (8%), Switzerland (7%), Hong Kong (6%), Italy (6%), the United Kingdom (4%), and others such as Korea, Finland, France, Germany, Australia, Portugal, and Norway. Recent portfolio adjustments reflect ongoing rebalancing to align with the index methodology, with top holdings shifts noted in late 2024 and 2025 filings showing increased emphasis on names like CSPC Pharmaceutical and APA Group amid quarterly dividend distributions including ex-dates in June 2025 ($1.31), March 2025 ($0.38), December 2024 ($0.69), and September 2024 ($0.61); no major acquisitions, funding rounds, or strategic reorganizations have been reported for the ETF itself in the last 1-2 years, though SSGA continues routine index reconstitutions and maintains a stable expense ratio of 0.40%.